This site may require a log-in in the near future. We are constantly being swamped by AI agents. If they continue to take down the site, we will be changing to requiring logins to access any item.

🍽️ vidarabine,(prescription)

AI Engines For more Details: Perplexity  Kagi Labs  You 

  1. Antiviral Activity: Vidarabine is a nucleoside analog antiviral medication that inhibits the replication of herpes simplex virus by interfering with viral DNA synthesis. It is effective against both herpes simplex virus type 1 (HSV-1) and herpes simplex virus type 2 (HSV-2).

  2. Treatment of Herpes Simplex Keratitis: Vidarabine is commonly used as a topical ophthalmic ointment or solution for the treatment of herpes simplex keratitis, a viral infection of the cornea that can cause eye pain, redness, tearing, and blurred vision. By inhibiting viral replication, vidarabine helps reduce the severity and duration of symptoms associated with herpes simplex keratitis.

  3. Herpes Simplex Virus Infections: In addition to herpes simplex keratitis, vidarabine may be used in the treatment of other localized herpes simplex virus infections, such as herpes labialis (cold sores) and herpes genitalis (genital herpes). It is applied directly to the affected area as a topical medication to suppress viral replication and promote healing.

  4. Mechanism of Action: Vidarabine exerts its antiviral effects by being phosphorylated intracellularly to its active form, vidarabine triphosphate. Vidarabine triphosphate competes with deoxyadenosine triphosphate (dATP) for incorporation into viral DNA by the viral DNA polymerase. Once incorporated, vidarabine triphosphate terminates viral DNA chain elongation, leading to inhibition of viral replication.

  5. Topical Administration: Vidarabine is typically administered as a topical ophthalmic ointment or solution for the treatment of herpes simplex keratitis. It is applied directly to the affected eye(s) several times daily as directed by a healthcare provider. The frequency and duration of treatment may vary depending on the severity of the infection and the patient's response to therapy.

  6. Adverse Effects: Common side effects associated with vidarabine therapy may include local irritation or burning sensation at the application site, transient blurred vision, and increased lacrimation (tearing). These side effects are usually mild and resolve spontaneously with continued use.

  7. Patient Monitoring: Patients receiving vidarabine therapy should be monitored regularly by a healthcare provider to assess treatment response, monitor for adverse effects, and ensure proper management of the underlying herpes simplex virus infection. Any worsening of symptoms or development of new ocular symptoms should be reported promptly to a healthcare provider.

  8. Contraindications: Vidarabine is contraindicated in patients with known hypersensitivity to the medication or any of its components. It should not be used in patients with active fungal, bacterial, or viral infections of the eye other than herpes simplex keratitis.

  9. Pregnancy and Lactation: The safety of vidarabine use during pregnancy or breastfeeding has not been well established. Healthcare providers should weigh the potential benefits and risks of treatment when considering the use of vidarabine in pregnant or lactating women.

  10. Drug Interactions: There are no significant drug interactions reported with vidarabine. However, patients should inform their healthcare provider about all medications, including prescription, over-the-counter, and herbal products, before starting vidarabine therapy to prevent potential drug interactions.

;

Check for interactions on Supp.AI   |   📚 PubMed Citations

⚗️ Compensation for antibiotic usage

Data Contradictions — Limits of Certainity

Impacted of vidarabine,(prescription) On Probiotics

Rank Probiotic Impact
genus Bifidobacterium Reduces
species Akkermansia muciniphila Reduces
species Anaerobutyricum hallii Reduces
species Bacteroides uniformis Reduces
species Bifidobacterium adolescentis Reduces
species Bifidobacterium breve Reduces
species Bifidobacterium catenulatum Reduces
species Bifidobacterium longum Reduces
species Blautia wexlerae Reduces
species Christensenella minuta Reduces
species Escherichia coli Reduces
species Lacticaseibacillus paracasei Reduces
species Lactococcus cremoris Reduces
species Lactococcus lactis Reduces
species Parabacteroides distasonis Reduces
species Veillonella atypica Reduces
subspecies Bifidobacterium longum subsp. infantis Reduces
subspecies Bifidobacterium longum subsp. longum Reduces

Bacteria Impacted by vidarabine,(prescription)

We extend modifiers to include items that changes the parent and child taxa. I.e. for a species, that would be the genus that is belongs to and the strains in the species.

🧙?

📓 Direct Citations 👪👶 Indirect Citations Taxonomy Rank Effect
0 1 Akkermansiaceae family Decreases
0 1 Bilophila genus Decreases
0 1 Blautia genus Decreases
0 1 Collinsella genus Decreases
0 1 Clostridioides genus Decreases
0 1 Veillonella genus Decreases
0 1 Clostridium genus Decreases
0 1 Dorea genus Decreases
0 1 Escherichia genus Decreases
0 1 Fusobacterium genus Decreases
0 1 Streptococcus genus Decreases
0 1 Bifidobacterium genus Decreases
0 1 Roseburia genus Decreases
0 1 Agathobacter genus Decreases
0 1 Odoribacter genus Decreases
0 1 Shigella genus Decreases
0 1 Mediterraneibacter genus Decreases
0 1 Parabacteroides genus Decreases
0 1 Bacteroides genus Decreases
0 1 Parolsenella genus Decreases
0 1 Olsenella genus Decreases
0 1 Anaerobutyricum genus Decreases
0 1 Lactococcus genus Decreases
0 1 Anaerostipes genus Decreases
0 1 Fannyhessea genus Decreases
0 1 Faecalibaculum genus Decreases
0 1 Faecalitalea genus Decreases
0 1 Allocoprobacillus genus Decreases
0 1 Phocaeicola genus Decreases
0 1 Lacrimispora genus Decreases
0 1 Lachnospira genus Decreases
0 1 Enterocloster genus Decreases
0 1 Lacticaseibacillus genus Decreases
1 0 Akkermansia genus Decreases
0 1 Clostridium perfringens A no rank Decreases
0 1 Clostridium perfringens B no rank Decreases
0 1 Clostridium perfringens C no rank Decreases
0 1 Clostridium perfringens CPE no rank Decreases
0 1 Clostridium perfringens D no rank Decreases
0 1 Clostridium perfringens E no rank Decreases
0 1 Escherichia coli O1:K1:H7 no rank Decreases
0 1 Escherichia coli O139:H1 no rank Decreases
0 1 Escherichia coli O141:H4 no rank Decreases
0 1 Escherichia coli O145:H34 no rank Decreases
0 1 Escherichia coli O15:H12 no rank Decreases
0 1 Escherichia coli O155:H21 no rank Decreases
0 1 Escherichia coli O158:H23 no rank Decreases
0 1 Escherichia coli O16:H48 no rank Decreases
0 1 Escherichia coli O170:H18 no rank Decreases
0 1 Escherichia coli O18ac:H14 no rank Decreases
0 1 Escherichia coli O19:H7 no rank Decreases
0 1 Escherichia coli O2:K1:H4 no rank Decreases
0 1 Escherichia coli O2:K1:H5 no rank Decreases
0 1 Escherichia coli O2:K1:H7 no rank Decreases
0 1 Escherichia coli O20:H12 no rank Decreases
0 1 Escherichia coli O25:H16 no rank Decreases
0 1 Escherichia coli O55:H7 no rank Decreases
0 1 Escherichia coli O68:H12 no rank Decreases
0 1 Escherichia coli O7:H15 no rank Decreases
0 1 Escherichia coli O78:H51 no rank Decreases
0 1 Escherichia coli O80:H26 no rank Decreases
0 1 Escherichia coli O84:H7 no rank Decreases
0 1 Escherichia coli O85:H1 no rank Decreases
0 1 environmental samples no rank Decreases
0 1 unclassified Akkermansia no rank Decreases
0 1 Escherichia coli O103 serogroup Decreases
0 1 Escherichia coli O111 serogroup Decreases
0 1 Escherichia coli O119 serogroup Decreases
0 1 Escherichia coli O121 serogroup Decreases
0 1 Escherichia coli O145 serogroup Decreases
0 1 Escherichia coli O155 serogroup Decreases
0 1 Escherichia coli O157 serogroup Decreases
0 1 Escherichia coli O177 serogroup Decreases
0 1 Escherichia coli O26 serogroup Decreases
0 1 Escherichia coli O3 serogroup Decreases
0 1 Escherichia coli O43 serogroup Decreases
0 1 Escherichia coli O5 serogroup Decreases
0 1 Escherichia coli O78 serogroup Decreases
0 1 Escherichia coli O86 serogroup Decreases
0 1 Escherichia coli O91 serogroup Decreases
0 1 Escherichia coli H20 serotype Decreases
0 1 Escherichia coli O1:H42 serotype Decreases
0 1 Escherichia coli O1:HNT serotype Decreases
0 1 Escherichia coli O10:H32 serotype Decreases
0 1 Escherichia coli O10:K5(L):H4 serotype Decreases
0 1 Escherichia coli O100:H21 serotype Decreases
0 1 Escherichia coli O103:H11 serotype Decreases
0 1 Escherichia coli O103:H2 serotype Decreases
0 1 Escherichia coli O103:H25 serotype Decreases
0 1 Escherichia coli O104:H21 serotype Decreases
0 1 Escherichia coli O104:H4 serotype Decreases
0 1 Escherichia coli O111:H- serotype Decreases
0 1 Escherichia coli O111:H11 serotype Decreases
0 1 Escherichia coli O111:H8 serotype Decreases
0 1 Escherichia coli O111:NM serotype Decreases
0 1 Escherichia coli O112ab:H8 serotype Decreases
0 1 Escherichia coli O112ac:H19 serotype Decreases
0 1 Escherichia coli O113:H21 serotype Decreases
0 1 Escherichia coli O114:H49 serotype Decreases
0 1 Escherichia coli O118:H16 serotype Decreases
0 1 Escherichia coli O121:H19 serotype Decreases
0 1 Escherichia coli O121:H7 serotype Decreases
0 1 Escherichia coli O123:H11 serotype Decreases
0 1 Escherichia coli O125ac:K+:H10 serotype Decreases
0 1 Escherichia coli O126:H45 serotype Decreases
0 1 Escherichia coli O127:H27 serotype Decreases
0 1 Escherichia coli O127:H6 serotype Decreases
0 1 Escherichia coli O128:H2 serotype Decreases
0 1 Escherichia coli O128ac:H12 serotype Decreases
0 1 Escherichia coli O139:H28 serotype Decreases
0 1 Escherichia coli O145:H25 serotype Decreases
0 1 Escherichia coli O145:H28 serotype Decreases
0 1 Escherichia coli O145:NM serotype Decreases
0 1 Escherichia coli O146:H21 serotype Decreases
0 1 Escherichia coli O15:H18 serotype Decreases
0 1 Escherichia coli O150:H6 serotype Decreases
0 1 Escherichia coli O152:H23 serotype Decreases
0 1 Escherichia coli O153:H2 serotype Decreases
0 1 Escherichia coli O156:H25 serotype Decreases
0 1 Escherichia coli O157:H- serotype Decreases
0 1 Escherichia coli O157:H43 serotype Decreases
0 1 Escherichia coli O157:H7 serotype Decreases
0 1 Escherichia coli O157:NM serotype Decreases
0 1 Escherichia coli O16:H6 serotype Decreases
0 1 Escherichia coli O165:H25 serotype Decreases
0 1 Escherichia coli O167:H26 serotype Decreases
0 1 Escherichia coli O174:H2 serotype Decreases
0 1 Escherichia coli O174:H21 serotype Decreases
0 1 Escherichia coli O174:H8 serotype Decreases
0 1 Escherichia coli O176:H45 serotype Decreases
0 1 Escherichia coli O177:NM serotype Decreases
0 1 Escherichia coli O2:H6 serotype Decreases
0 1 Escherichia coli O2:K2:H1 serotype Decreases
0 1 Escherichia coli O25:H1 serotype Decreases
0 1 Escherichia coli O25:NM serotype Decreases
0 1 Escherichia coli O26:H1 serotype Decreases
0 1 Escherichia coli O26:H11 serotype Decreases
0 1 Escherichia coli O28ac:NM serotype Decreases
0 1 Escherichia coli O29:H4 serotype Decreases
0 1 Escherichia coli O32:H37 serotype Decreases
0 1 Escherichia coli O39:NM serotype Decreases
0 1 Escherichia coli O44:H18 serotype Decreases
0 1 Escherichia coli O45:H2 serotype Decreases
0 1 Escherichia coli O6:H16 serotype Decreases
0 1 Escherichia coli O6:H16:CFA/II serotype Decreases
0 1 Escherichia coli O6:K2:H1 serotype Decreases
0 1 Escherichia coli O69:H11 serotype Decreases
0 1 Escherichia coli O7:H4 serotype Decreases
0 1 Escherichia coli O7:K1 serotype Decreases
0 1 Escherichia coli O78:H12 serotype Decreases
0 1 Escherichia coli O78:H4 serotype Decreases
0 1 Escherichia coli O79:H7 serotype Decreases
0 1 Escherichia coli O8:H8 serotype Decreases
0 1 Escherichia coli O81:NM serotype Decreases
0 1 Escherichia coli O83:H1 serotype Decreases
0 1 Escherichia coli O86:H34 serotype Decreases
0 1 Escherichia coli O89m:H10 serotype Decreases
0 1 Escherichia coli O89m:H9 serotype Decreases
0 1 Escherichia coli O9:H10 serotype Decreases
0 1 Escherichia coli O91:H14 serotype Decreases
0 1 Escherichia coli O91:NM serotype Decreases
0 1 Escherichia coli O99:H6 serotype Decreases
0 1 Escherichia coli ONT:H33 serotype Decreases
1 0 Bacteroides ovatus species Decreases
1 0 Bacteroides caccae species Decreases
1 0 Escherichia coli species Decreases
1 0 Fusobacterium nucleatum species Decreases
1 0 Bifidobacterium adolescentis species Decreases
1 0 Bilophila wadsworthia species Decreases
1 0 Blautia obeum species Decreases
1 0 Clostridioides difficile species Decreases
1 0 Clostridium perfringens species Decreases
1 0 Collinsella aerofaciens species Decreases
1 0 Dorea formicigenerans species Decreases
1 0 Roseburia hominis species Decreases
1 0 Streptococcus parasanguinis species Decreases
1 0 Veillonella parvula species Decreases
1 0 Mediterraneibacter gnavus species Decreases
1 0 Agathobacter rectalis species Decreases
1 0 Parabacteroides merdae species Decreases
1 0 Odoribacter splanchnicus species Decreases
1 0 Streptococcus salivarius species Decreases
0 1 Shigella dysenteriae species Decreases
0 1 Shigella flexneri species Decreases
0 1 Escherichia albertii species Decreases
0 1 Streptococcus sp. LPB0220 species Decreases
0 1 Veillonella rodentium species Decreases
0 1 Streptococcus sp. HSISM1 species Decreases
1 0 Bacteroides uniformis species Decreases
1 0 Bifidobacterium longum species Decreases
1 0 Parabacteroides distasonis species Decreases
1 0 Bacteroides xylanisolvens species Decreases
0 1 Escherichia fergusonii species Decreases
0 1 Streptococcus sp. FDAARGOS_192 species Decreases
0 1 Shigella boydii species Decreases
0 1 Veillonella dispar species Decreases
1 0 [Ruminococcus] torques species Decreases
0 1 Veillonella sp. S12025-13 species Decreases
0 1 Veillonella nakazawae species Decreases
0 1 Parolsenella catena species Decreases
1 0 Roseburia intestinalis species Decreases
1 0 Phocaeicola vulgatus species Decreases
0 1 Bifidobacterium angulatum species Decreases
0 1 Veillonella rogosae species Decreases
0 1 Parolsenella massiliensis species Decreases
1 0 Bacteroides fragilis species Decreases
0 1 Actinomyces naeslundii species Decreases
0 1 Shigella sonnei species Decreases
0 1 Anaerobutyricum hallii species Decreases
0 1 Collinsella stercoris species Decreases
0 1 Coprococcus catus species Decreases
0 1 Escherichia marmotae species Decreases
0 1 Dorea longicatena species Decreases
0 1 Blautia sp. SC05B48 species Decreases
0 1 Escherichia sp. E4742 species Decreases
0 1 Olsenella sp. oral taxon 807 species Decreases
0 1 Wansuia hejianensis species Decreases
0 1 Streptococcus lactarius species Decreases
0 1 Fannyhessea vaginae species Decreases
0 1 Veillonella atypica species Decreases
0 1 Komagataeibacter oboediens species Decreases
0 1 Streptococcus vestibularis species Decreases
0 1 Adlercreutzia equolifaciens species Decreases
0 1 Bacteroides luhongzhouii species Decreases
0 1 Eubacterium ventriosum species Decreases
0 1 Coprococcus comes species Decreases
0 1 Streptococcus gordonii species Decreases
0 1 Ligilactobacillus ruminis species Decreases
0 1 Bacteroides sp. D2 species Decreases
0 1 Butyrivibrio crossotus species Decreases
0 1 Actinomyces oris species Decreases
0 1 Ruminococcus albus species Decreases
0 1 Streptococcus australis species Decreases
0 1 Eubacterium limosum species Decreases
0 1 Phoenicibacter congonensis species Decreases
0 1 Bacillus paralicheniformis species Decreases
0 1 Subdoligranulum variabile species Decreases
0 1 Blautia liquoris species Decreases
0 1 Qiania dongpingensis species Decreases
0 1 Streptococcus sp. oral taxon 061 species Decreases
0 1 Eubacterium sp. MSJ-33 species Decreases
0 1 Clostridium sp. M62/1 species Decreases
0 1 Eubacterium callanderi species Decreases
0 1 Ruminococcus gauvreauii species Decreases
0 1 Mogibacterium diversum species Decreases
0 1 Actinomyces sp. oral taxon 171 species Decreases
0 1 Parvimonas micra species Decreases
0 1 Clostridium sp. SY8519 species Decreases
0 1 Novisyntrophococcus fermenticellae species Decreases
0 1 Faecalibacillus intestinalis species Decreases
0 1 Blautia argi species Decreases
0 1 Bacteroides sp. DH3716P species Decreases
0 1 Anaerostipes hadrus species Decreases
0 1 uncultured Alistipes sp. species Decreases
0 1 Bacteroides sp. M10 species Decreases
0 1 Corynebacterium durum species Decreases
0 1 Faecalitalea cylindroides species Decreases
0 1 Eubacterium maltosivorans species Decreases
0 1 Eubacterium sp. c-25 species Decreases
0 1 Streptococcus infantis species Decreases
0 1 Intestinibaculum porci species Decreases
0 1 Roseburia rectibacter species Decreases
0 1 Parafannyhessea umbonata species Decreases
0 1 Massilistercora timonensis species Decreases
0 1 Faecalibacterium duncaniae species Decreases
0 1 Ruthenibacterium lactatiformans species Decreases
0 1 [Eubacterium] hominis species Decreases
0 1 Alistipes sp. dk3624 species Decreases
0 1 Streptococcus oralis species Decreases
0 1 Actinomyces sp. oral taxon 169 species Decreases
0 1 Christensenella minuta species Decreases
0 1 Clostridium sp. C1 species Decreases
0 1 [Ruminococcus] lactaris species Decreases
0 1 Coprococcus eutactus species Decreases
1 0 Lacrimispora saccharolytica species Decreases
0 1 Pseudobutyrivibrio xylanivorans species Decreases
0 1 Lactococcus lactis species Decreases
0 1 Alistipes ihumii species Decreases
0 1 Streptococcus suis species Decreases
0 1 Amedibacterium intestinale species Decreases
0 1 Wujia chipingensis species Decreases
0 1 Marvinbryantia formatexigens species Decreases
0 1 Alistipes megaguti species Decreases
0 1 Lachnoclostridium phocaeense species Decreases
0 1 Gordonibacter urolithinfaciens species Decreases
0 1 Bacteroides sp. CACC 737 species Decreases
0 1 [Clostridium] hylemonae species Decreases
0 1 Longicatena caecimuris species Decreases
0 1 Catenibacterium mitsuokai species Decreases
0 1 Treponema denticola species Decreases
0 1 Mageeibacillus indolicus species Decreases
0 1 Vescimonas coprocola species Decreases
0 1 Lachnoanaerobaculum gingivalis species Decreases
0 1 Butyricimonas virosa species Decreases
0 1 Monoglobus pectinilyticus species Decreases
0 1 Clostridium cadaveris species Decreases
0 1 Dysosmobacter welbionis species Decreases
0 1 Vescimonas fastidiosa species Decreases
0 1 Streptococcus mutans species Decreases
0 1 Lactococcus cremoris species Decreases
0 1 Maliibacterium massiliense species Decreases
0 1 Bifidobacterium catenulatum species Decreases
0 1 Phascolarctobacterium succinatutens species Decreases
0 1 Faecalibaculum rodentium species Decreases
0 1 Streptococcus sp. oral taxon 431 species Decreases
0 1 Campylobacter coli species Decreases
0 1 Bifidobacterium breve species Decreases
0 1 Butyrivibrio fibrisolvens species Decreases
0 1 Alistipes dispar species Decreases
0 1 Coprococcus sp. ART55/1 species Decreases
0 1 Arabiibacter massiliensis species Decreases
0 1 Rothia dentocariosa species Decreases
0 1 Ruminococcus bicirculans (ex Wegman et al. 2014) species Decreases
0 1 Blautia wexlerae species Decreases
0 1 Solibaculum mannosilyticum species Decreases
0 1 Faecalibacterium sp. I4-3-84 species Decreases
0 1 Streptococcus sp. Marseille-Q6470 species Decreases
1 0 Lachnospira eligens species Decreases
1 0 Enterocloster bolteae species Decreases
1 0 Bacteroides thetaiotaomicron species Decreases
1 0 Lacticaseibacillus paracasei species Decreases
1 0 Akkermansia muciniphila species Decreases
0 1 Akkermansia glycaniphila species Decreases
0 1 Akkermansia massiliensis species Decreases
0 1 Candidatus Akkermansia intestinavium species Decreases
0 1 Fusobacterium nucleatum subsp. nucleatum subspecies Decreases
0 1 Bifidobacterium longum subsp. infantis subspecies Decreases
0 1 Bifidobacterium longum subsp. longum subspecies Decreases
0 1 Bifidobacterium longum subsp. suillum subspecies Decreases
0 1 Bifidobacterium longum subsp. suis subspecies Decreases
0 1 Lacticaseibacillus paracasei subsp. paracasei subspecies Decreases
0 1 Lacticaseibacillus paracasei subsp. tolerans subspecies Decreases

Impact of vidarabine,(prescription) on Conditions from US National Library of Medicine

A higher number indicates impact on more bacteria associated with the condition and confidence on the impact.

We have X bacteria high and Y low reported. We find that the modifier reduces some and increases other of these two groups. We just tally: X|reduces + Y|Increase = Positive   X|increases + Y|decrease = Negative.

Benefit Ratio:
Numbers above 0 have increasing positive effect.
Numbers below 0 have increasing negative effect.

Condition Positive Impact Negative Impact Benefit Ratio Impact
Abdominal Aortic Aneurysm 0.5 0.5
Acne 0.3 -0.3
ADHD 3.7 0.3 11.33
Age-Related Macular Degeneration and Glaucoma 0.8 0.2 3
Allergic Rhinitis (Hay Fever) 3.3 3 0.1
Allergies 6.6 1.8 2.67
Allergy to milk products 1.7 1.2 0.42
Alopecia (Hair Loss) 1.9 0.1 18
Alzheimer's disease 6.1 6.6 -0.08
Amyotrophic lateral sclerosis (ALS) Motor Neuron 1.9 0.8 1.37
Ankylosing spondylitis 4.1 1.1 2.73
Anorexia Nervosa 1.7 2.5 -0.47
Antiphospholipid syndrome (APS) 1.2 0.5 1.4
Asthma 5 2.1 1.38
Atherosclerosis 2.3 1.3 0.77
Atrial fibrillation 2.9 2.2 0.32
Autism 7.2 7.8 -0.08
Autoimmune Disease 1.2 1 0.2
Barrett esophagus cancer 0.8 0.3 1.67
benign prostatic hyperplasia 0.5 0.2 1.5
Biofilm 3.3 3.3
Bipolar Disorder 1.8 0.7 1.57
Brain Trauma 1.2 0.7 0.71
Breast Cancer 1.3 1.3
Cancer (General) 1 2.4 -1.4
Carcinoma 4.4 2.3 0.91
Celiac Disease 2.6 3.2 -0.23
Cerebral Palsy 1.6 1 0.6
Chronic Fatigue Syndrome 5.1 6.1 -0.2
Chronic Kidney Disease 4.4 2.3 0.91
Chronic Lyme 0.6 0.4 0.5
Chronic Obstructive Pulmonary Disease (COPD) 2.9 1.4 1.07
Chronic Urticaria (Hives) 2.1 0.2 9.5
Coagulation / Micro clot triggering bacteria 1.7 1.2 0.42
Cognitive Function 1.8 1.5 0.2
Colorectal Cancer 6.6 2.9 1.28
Constipation 1 0.8 0.25
Coronary artery disease 3.1 2.6 0.19
COVID-19 9.1 9.8 -0.08
Crohn's Disease 8.3 4.2 0.98
Cushing's Syndrome (hypercortisolism) 0.4 -0.4
cystic fibrosis 1 1.8 -0.8
d-lactic acidosis (one form of brain fog) 0.8 0.8
deep vein thrombosis 2.3 0.9 1.56
Denture Wearers Oral Shifts 2.2 2.2
Depression 9 7.6 0.18
Dermatomyositis 0.3 0.3 0
Eczema 2.6 2.2 0.18
Endometriosis 3.2 1.6 1
Eosinophilic Esophagitis 0.3 0.7 -1.33
Epilepsy 4.3 1.7 1.53
erectile dysfunction 1.4 0.4 2.5
Fibromyalgia 2.6 1.4 0.86
Functional constipation / chronic idiopathic constipation 4.5 3 0.5
gallstone disease (gsd) 3.7 0.9 3.11
Gastroesophageal reflux disease (Gerd) including Barrett's esophagus 1.9 1.7 0.12
Generalized anxiety disorder 3.2 1.5 1.13
giant cell arteritis 0.4 -0.4
Glioblastoma 0.4 -0.4
Gout 1.4 0.6 1.33
Graves' disease 1.6 3.1 -0.94
Gulf War Syndrome 1.2 0.6 1
Halitosis 1.9 0.4 3.75
Hashimoto's thyroiditis 3.1 1.2 1.58
Heart Failure 4.3 1.9 1.26
hemorrhagic stroke 0.9 0.9
Hidradenitis Suppurativa 1.4 0.4 2.5
High Histamine/low DAO 1.9 0.3 5.33
hypercholesterolemia (High Cholesterol) 1.3 0 0
hyperglycemia 2.3 1.2 0.92
Hyperlipidemia (High Blood Fats) 1.4 0.5 1.8
hypersomnia 1.6 -1.6
hypertension (High Blood Pressure 4.1 4.3 -0.05
Hypothyroidism 0 0.9 0
Hypoxia 2.1 2.1
IgA nephropathy (IgAN) 1.1 3.9 -2.55
Inflammatory Bowel Disease 9.5 8.5 0.12
Insomnia 2.3 2.2 0.05
Intelligence 1.8 1.8
Intracranial aneurysms 1.2 0.5 1.4
Irritable Bowel Syndrome 7.7 3.8 1.03
ischemic stroke 2.9 1.4 1.07
Juvenile idiopathic arthritis 0.1 0.1
Liver Cirrhosis 7.3 3.9 0.87
Long COVID 5.7 6.3 -0.11
Low bone mineral density 0.1 0.6 -5
Lung Cancer 1.7 1.1 0.55
Lymphoma 0.5 0.5
Mast Cell Issues / mastitis 1.5 0.3 4
ME/CFS with IBS 0.8 2.3 -1.87
ME/CFS without IBS 1.4 1.9 -0.36
membranous nephropathy 0.3 0.3
Menopause 2.2 0.4 4.5
Metabolic Syndrome 8.4 6.7 0.25
Mood Disorders 9.2 6.2 0.48
multiple chemical sensitivity [MCS] 1.1 0.5 1.2
Multiple Sclerosis 6.4 4.8 0.33
Multiple system atrophy (MSA) 1.2 0.8 0.5
myasthenia gravis 0.9 0.7 0.29
neuropathic pain 1.9 -1.9
Neuropathy (all types) 0.8 1.3 -0.63
neuropsychiatric disorders (PANDAS, PANS) 1.2 1.2
Nonalcoholic Fatty Liver Disease (nafld) Nonalcoholic 5.2 3.8 0.37
NonCeliac Gluten Sensitivity 1.5 0.5 2
Obesity 9.9 6.9 0.43
obsessive-compulsive disorder 5 3.1 0.61
Osteoarthritis 2.8 0.9 2.11
Osteoporosis 1.8 1.7 0.06
pancreatic cancer 1.2 0.3 3
Parkinson's Disease 7.3 5.3 0.38
Polycystic ovary syndrome 5.4 2.7 1
Postural orthostatic tachycardia syndrome 0.4 0.3 0.33
Premenstrual dysphoric disorder 1.3 0.2 5.5
primary biliary cholangitis 1.1 1.8 -0.64
Primary sclerosing cholangitis 3.3 2.9 0.14
Psoriasis 4 1.5 1.67
rheumatoid arthritis (RA),Spondyloarthritis (SpA) 6.5 4.3 0.51
Rosacea 0.5 0.7 -0.4
Schizophrenia 6.6 2.4 1.75
scoliosis 0.8 0.6 0.33
sensorineural hearing loss 0.3 0.3
Sjögren syndrome 3 2.7 0.11
Sleep Apnea 1.7 1 0.7
Slow gastric motility / Gastroparesis 1.3 0.3 3.33
Small Intestinal Bacterial Overgrowth (SIBO) 2.3 0.3 6.67
Stress / posttraumatic stress disorder 3 1.4 1.14
Systemic Lupus Erythematosus 4.3 1.4 2.07
Tic Disorder 0.7 1.4 -1
Tourette syndrome 0.7 0.2 2.5
Type 1 Diabetes 4.1 2.8 0.46
Type 2 Diabetes 8 5.5 0.45
Ulcerative colitis 6 4.9 0.22
Unhealthy Ageing 4.6 1.5 2.07
Vitiligo 1.2 1 0.2

Explanations /Info /Descriptions are influenced by Large Language Models and may not be accurate and include some hallucinations.Please report any to us for correction.

Copyright 2016 - 2025 Lassesen Consulting, LLC[2007], DBA, Microbiome Prescription All rights served.   Permission to data scrap or reverse engineer is explicitly denied to all users.U.S.Code Title 18 PART I CHAPTER 47 § 1030, CETS No.185, CFAA   Use of data on this site is prohibited except under written license.There is no charge for individual personal use.Use for any commercial applications or research requires a written license.   Caveat emptor: Analysis and suggestions are based on modelling(and thus infererence ) based on studies.The data sources are usually given for those that wish to consider alternative inferences.theories and models.   Inventions /Methodologies on this site are Patent Pending.

Microbiome Prescription do not make any representations that data or analyses available on this site is suitable for human diagnostic purposes, for informing treatment decisions, or for any other purposes and accept no responsibility or liability whatsoever for such use.
This site is not in strict compliance with Personal Health Information Laws. [216.73.216 ]